Категории

Cirrhosis Prognosis: The Child-Pugh Score

Опубликовано: 27 Февраль 2020
на канале: OncLive
16,948
95

Expert oncologists discuss the importance of the Child-Pugh score to stratify and prognosticate cirrhosis-related hepatocellular carcinoma.

Смотрите видео Cirrhosis Prognosis: The Child-Pugh Score онлайн без регистрации, длительностью часов минут секунд в хорошем качестве. Это видео добавил пользователь OncLive 27 Февраль 2020, не забудьте поделиться им ссылкой с друзьями и знакомыми, на нашем сайте его посмотрели 16,948 раз и оно понравилось 95 людям.

play_arrow
592
27

Танец Фокси аниме фнаф

Танец Фокси аниме фнаф
play_arrow
64
1

👩‍💻 Коммуникации сотрудников в корпоративном портале Битрикс24 (сообщения и чаты)

👩‍💻 Коммуникации сотрудников в корпоративном портале Битрикс24 (сообщения и чаты)
play_arrow
1,236
7

Молодежный рюкзак Asgard Р-5434 - видеообзор от Rightbag.ru

Молодежный рюкзак Asgard Р-5434 - видеообзор от Rightbag.ru
play_arrow
326
7

ANTHEM | BENCHMARK RX 6600XT | MEDIUM AND ULTRA SETTINGS

ANTHEM | BENCHMARK RX 6600XT | MEDIUM AND ULTRA SETTINGS
play_arrow
1

Let's Rip Pokemon! !discord !shop !marketplace

Let's Rip Pokemon! !discord !shop !marketplace
play_arrow
120,904
5.9 тыс

WHAT HAPPENED TO DRE?! | Rapper Reacts to Eminem I NEED A DOCTOR

WHAT HAPPENED TO DRE?! | Rapper Reacts to Eminem I NEED A DOCTOR
play_arrow
2,973
31

Китайская еда

Китайская еда

play_arrow
99
0

VAIIYA WE. AS ONE | THE FINALS

VAIIYA WE. AS ONE | THE FINALS
Похожие видео
play_arrow
Precision Medicine in Metastatic Triple Negative Breast Cancer

Precision Medicine in Metastatic Triple Negative Breast Cancer
play_arrow
Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 Insertion

Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 Insertion
play_arrow
EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer

EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer
play_arrow
OncLive News Network On Location: ASCO 2020 Day 1

OncLive News Network On Location: ASCO 2020 Day 1
play_arrow
Diagnosis of Neurofibromatosis Type 1

Diagnosis of Neurofibromatosis Type 1
play_arrow
Dr. Lopes on the Rationale to Stop Immunotherapy After 2 Years in Lung Cancer

Dr. Lopes on the Rationale to Stop Immunotherapy After 2 Years in Lung Cancer
play_arrow
Novel Treatments in HER2-Positive Breast Cancer

Novel Treatments in HER2-Positive Breast Cancer
play_arrow
Lurbinectedin’s Role in Managing SCLC

Lurbinectedin’s Role in Managing SCLC
play_arrow
Dr. Rizvi on the Limitations of ABVD in Hodgkin Lymphoma

Dr. Rizvi on the Limitations of ABVD in Hodgkin Lymphoma
play_arrow
Therapy Options for Hepatitis B/C–Related HCC

Therapy Options for Hepatitis B/C–Related HCC
play_arrow
Treating Patients With Essential Thrombocytopenia

Treating Patients With Essential Thrombocytopenia
play_arrow
Biology of Clear Cell Renal Cell Carcinoma

Biology of Clear Cell Renal Cell Carcinoma
play_arrow
The Use of Ruxolitinib in Myelofibrosis

The Use of Ruxolitinib in Myelofibrosis
play_arrow
Current Treatment Landscape of Soft Tissue Sarcoma

Current Treatment Landscape of Soft Tissue Sarcoma
play_arrow
Diagnostic Testing Procedure for Soft Tissue Sarcoma

Diagnostic Testing Procedure for Soft Tissue Sarcoma
play_arrow
Treatment Landscape of Castrate-Resistant Prostate Cancer

Treatment Landscape of Castrate-Resistant Prostate Cancer
play_arrow
Lenalidomide in Del 5q MDS

Lenalidomide in Del 5q MDS
play_arrow
MDS: Low-Risk Disease Treatment Options

MDS: Low-Risk Disease Treatment Options
play_arrow
Neoadjuvant Treatment for Triple-Negative Breast Cancer

Neoadjuvant Treatment for Triple-Negative Breast Cancer
play_arrow
Dr. Coleman on the VELIA Trial Impact on Ovarian Cancer Practice

Dr. Coleman on the VELIA Trial Impact on Ovarian Cancer Practice
play_arrow
Dr. Tsao on Rationale for Staging Renal Cell Carcinoma

Dr. Tsao on Rationale for Staging Renal Cell Carcinoma
play_arrow
Cirrhosis Prognosis: The Child-Pugh Score

Cirrhosis Prognosis: The Child-Pugh Score
play_arrow
Dr. Tan on the Risk of Novel Coronavirus for Patients With Cancer

Dr. Tan on the Risk of Novel Coronavirus for Patients With Cancer
play_arrow
Dr. Corcoran on Targeting HER2 Amplification in CRC

Dr. Corcoran on Targeting HER2 Amplification in CRC